Dr. Reddy's Labs Files 6-K with Updated Info
Ticker: RDY · Form: 6-K · Filed: Aug 13, 2025 · CIK: 1135951
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
Related Tickers: RDY
TL;DR
DRL filed a 6-K on 8/13/25, just an admin update for their 20-F filing.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on August 13, 2025, confirming its status as a foreign private issuer filing annual reports under Form 20-F. The filing provides updated contact and address information for its principal executive office located in Hyderabad, Telangana, India.
Why It Matters
This filing serves as an administrative update for investors and regulatory bodies, confirming Dr. Reddy's compliance with reporting requirements as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically impact risk.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Registrant
- 0001575872-25-000536 (filing_id) — Accession Number
- 20250813 (date) — Filing Date
- Hyderabad, Telangana, India (location) — Principal Executive Office
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used by Dr. Reddy's Laboratories Ltd. to submit information to the SEC.
When was this Form 6-K filed?
This Form 6-K was filed on August 13, 2025.
Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or 40-F?
Dr. Reddy's Laboratories Ltd. indicated by check mark that it files annual reports under cover of Form 20-F.
Where is the principal executive office of Dr. Reddy's Laboratories Ltd. located?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
What is the Commission File Number for Dr. Reddy's Laboratories Ltd.?
The Commission File Number for Dr. Reddy's Laboratories Ltd. is 1-15182.
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-08-13 06:40:37
Filing Documents
- rdy0793_6k.htm (6-K) — 47KB
- rdy0793_ex99-1.htm (EX-99.1) — 35KB
- rdy0793_ex99-1img01.jpg (GRAPHIC) — 3KB
- rdy0793_ex99-1img02.jpg (GRAPHIC) — 7KB
- 0001575872-25-000536.txt ( ) — 97KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: August 13, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3